Central depressor action of nitric oxide is deficient in genetic hypertension

American Journal of Hypertension

Volumn 9, Issue 3, 1996, Pages 237-241

  Cabrera, Camilo L ^a   Bealer, Steven L ^b   Bohr, David F ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Anteroventral third cerebral ventricle (AV3V); Cyclic guanosine monophosphate (cGMP); N( ) nitro L arginine methyl ester (L NAME); Nitric oxide; Stroke prone spontaneously hypertensive rat

Indexed keywords

CALCIUM; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN THIRD VENTRICLE; CONTROLLED STUDY; DRUG ADMINISTRATION; DRUG EFFECT; ENZYME ACTIVITY; HEREDITARY HYPERTENSION; HYPOTHESIS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0029925382     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00292-8     Document Type: Article

References (19)

1. Shapoval L, Sagach V, Pobegailo L: Nitric oxide influences ventrolateral medullary mechanisms of vasomotor control in the cat. Neurosci Lett 1991;132:47-50.
2. Cabrera C, Bohr D: The role of nitric oxide in the central control of blood pressure. Biochem Biophys Res Commun 1995;206:77-81.
3. Malinski T, Kapturczak M, Dayharsh J, et al: Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun 1993;194:654-658.
4. Maragos CM, Morley D, Wink DA, et al: Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 1991;4:3242-3247.
5. Knoles RG, Placios M, Palmer RMJ, et al: Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci USA 1989;86:5159-5162.
6. Butt E, Bemmelen VM, Fisher L, et al: Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorathioates. Eur J Biochem 1990;263: 47-50.
7. Togashi H, Sakuma I, Yoshioka M, et al: A central nervous system action of nitric oxide in blood pressure regulation. J Pharm Exp Therap 1992;262:343-347.
8. Lewis S, Machado B, Ohta H, et al: Cardiovascular effects of the EDRF candidate S-nitrosocysteine (S-NC) microinjected into the nucleus tractus solitarius (NTS) of rats (abst). FASEB J 1991;5:A1411.
9. Lewis S, Ohta H, Machado B, et al: Microinjection of S-nitrosocysteine into the nucleus tractus solitarii decreases arterial pressure and heart rate via activation of soluble guanylate cyclase. Eur J Pharmacol 1991;202: 135-136.
10. Tagawa T, Imaizumi T, Harada S, et al: Nitric oxide influences neuronal activity in the nucleus tractus solitarius of rat brainstem slices. Circ Res 1994;75:70-76.
11. Harada S, Tokunaga S, Mohohara M, et al: Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 1993;72:511-516.
12. Horn T, Smith P, McLaughlin B, et al: Nitric oxide actions in paraventricular nucleus: cardiovascular and neurochemical implications. Am J Physiol 1994;266: R306-R313.
13. Buggy J, Johnson AK: Angiotesin-induced thirst: effects of third ventricle obstruction and periventricular ablation. Brain Res 1978;149:117-129.
14. Brody MJ, Johnson AK: Role of the anteroventral third ventricle region in fluid and electrolyte balance, arterial pressure regulation and hypertension, in Martini L, Ganong WF (eds): Frontiers in Neuroendrocinology. New York, Raven, 1980, pp 249-292.
15. Brody MJ, Varner JK, Vasquez EC, et al: Central nervous system and the pathogenesis of hypertension: sites and mechanisms. Hypertension 1991;18(suppl III):III-7-III-12.
16. ω-nitro-L-arginine) on blood pressure and plasma rennin. Clin Exp Hypertens [A] 1993;15:819-832.
17. Smith JK, Barron KW: Cardiovascular effects of L-glutamate and tetrodotoxin microinjected into the rostral and caudal ventrolateral medulla in normotensive and spontaneously hypertensive rats. Brain Res 1990; 506:1-8.
18. Kubo T, Nagura J, Kihara M, et al: Cardiovascular effects of L-glutamate and gamma-aminobutyric acid injected into the rostral ventrolateral medulla in normotensive and spontaneously hypertensive rats. Arch Int Pharmacodyn Ther 1986;279:150-161.
19. Brody MJ, Fink GD, Buggy J, et al: The role of anteroventral third ventricle (AV3V) region in experimental hypertension. Circ Res 1978;43(suppl I):I-2-I-13.